support@nanobiousa.com

1-888-678-8889 (USA)

Nanobio Delivery in AACR 2017 Annual Meeting

At the AACR (American Association for Cancer Research) Annual Meeting 2017 from April 1-5 at Washington D.C. USA, Nanobio Delivery has introduced the emerging RNA technology for cancer cell targeted drug delivery system, especially for small RNA or DNA based therapeutics. The RNA nanotechnology platform helps to find a way to systemically deliver desired small nucleic acid based therapeutics under research in vivo.
To find out more, visit Nanobio Delivery company website at www.nanobiousa.com 
Copyright © Nanobio Delivery Pharmaceutical Co., Ltd. All rights reserved.